Edwards Lifesciences (EW): Sen. Markwayne Mullin disclosed a partial sale $15K–$50K
Sen. Markwayne Mullin disclosed a partial sale of Edwards Lifesciences in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 30 days
- Disclosure lag
- Traded
- Aug 20, 2024
- Disclosed
- Sep 19, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 27, 2024FDAFDA device clearance: Swan-Ganz Pacing Probe and Catheters; Swan-Ganz Bipolar Pacing Catheter (D97120F5); Swan-Ganz Bipolar Pacing Catheter (D97130F5); Swan-Ganz Pacing Thermodiluti…
- Jul 2, 2024FDAFDA device clearance: Fogarty Fortis Arterial Embolectomy Catheter
- Aug 2, 2024FDAFDA device clearance: Acumen Assisted Fluid Management (AFM) Software Feature
- Aug 20, 2024 · this disclosureCongressDisclosed partial sale of EW — reported range $15,001 - $50,000
What came next
- Aug 28, 2024FDAFDA device clearance: Fogarty Thru-Lumen Embolectomy Catheter
- Oct 14, 2024Court · District Court, C.D. CaliforniaSecurities lawsuit filed: Dhimant Patel v. Edwards Lifesciences Corporation
- Oct 15, 2024InsiderOfficer sold ~$348K of EW shares in the open market
- Oct 16, 2024FDAFDA device clearance: Cerebral Autoregulation Index (CAI) Algorithm
- Nov 5, 2024InsiderOfficer sold ~$1.65M of EW shares in the open market
- Nov 13, 2024InsiderOfficer sold ~$328K of EW shares in the open market
- Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$171K)
- Dec 9, 2024FDAFDA device clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1/ALTCR1/ALTASR1); HemoSphere Alta- monitor pressure cable (HEMAPSC200);Acumen AFM cable- HemoSphere Alta…
- Dec 9, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
- Dec 16, 2024InsiderOfficer sold ~$185K of EW shares in the open market
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Edwards Lifesciences
For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.
Other recent filings by Sen. Markwayne Mullin
- Senate eFD periodic transaction report at UnitedHealth (UNH)Mar 10, 2026
- Senate eFD periodic transaction report at AutoZone (AZO)Mar 10, 2026
- Senate eFD periodic transaction report at Intuit (INTU)Mar 10, 2026
- Senate eFD periodic transaction report at Monolithic Power Systems (MPWR)Mar 2, 2026
- Senate eFD periodic transaction report at McKesson Corporation (MCK)Mar 2, 2026
The full history of Sen. Markwayne Mullin is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Edwards Lifesciences (EW) stock, and how much?
Sen. Markwayne Mullin disclosed a partial sale of Edwards Lifesciences in the $15K–$50K range. Reported range, not an exact amount, Joint account.
When did it happen, and when was it made public?
Traded: Aug 20, 2024. Disclosed: Sep 19, 2024. That is 30 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the Senate eFD periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Edwards Lifesciences recently?
For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the EW page.
Does this mean EW stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Edwards Lifesciences
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its EW page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
